Ferroptosis Regulator Information
General Information of the Ferroptosis Regulator (ID: REG20060)
Full List of the Ferroptosis Target of This Regulator and Corresponding Disease/Drug Response(s)
hsa-miR-4735-3p
can regulate the following target(s), and cause disease/drug response(s). You can browse detail information of target(s) or disease/drug response(s).
Browse Target
Browse Disease
Solute carrier family 40 member 1 (SLC40A1) [Suppressor; Marker]
In total 1 item(s) under this target | ||||
Experiment 1 Reporting the Ferroptosis Target of This Regulator | [1] | |||
Target for Ferroptosis | Marker/Suppressor | |||
Responsed Disease | Hereditary Leiomyomatosis | ICD-11: 2C90 | ||
Pathway Response | Fatty acid metabolism | hsa01212 | ||
Ferroptosis | hsa04216 | |||
Cell Process | Cell ferroptosis | |||
Cell proliferation | ||||
Cell migration | ||||
Cell invasion | ||||
In Vitro Model |
786-O cells | Renal cell carcinoma | Homo sapiens | CVCL_1051 |
A-498 cells | Renal cell carcinoma | Homo sapiens | CVCL_1056 | |
HK-2 cells | Normal | Homo sapiens | CVCL_0302 | |
Response regulation | The miR-4735-3p mimic increased, while the miR-4735-3p inhibitor decreased oxidative stress, lipid peroxidation, iron overload, and ferroptosis of human Clear cell renal cell carcinoma (ccRCC) cell lines. Mechanistic studies identified SLC40A1 as a direct target of miR-4735-3p. | |||
Hereditary Leiomyomatosis [ICD-11: 2C90]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the Ferroptosis-centered Disease Response | [1] | |||
Target Regulator | hsa-miR-4735-3p (miRNA) | miRNA | ||
Pathway Response | Fatty acid metabolism | hsa01212 | ||
Ferroptosis | hsa04216 | |||
Cell Process | Cell ferroptosis | |||
Cell proliferation | ||||
Cell migration | ||||
Cell invasion | ||||
In Vitro Model |
786-O cells | Renal cell carcinoma | Homo sapiens | CVCL_1051 |
A-498 cells | Renal cell carcinoma | Homo sapiens | CVCL_1056 | |
HK-2 cells | Normal | Homo sapiens | CVCL_0302 | |
Response regulation | The miR-4735-3p mimic increased, while the miR-4735-3p inhibitor decreased oxidative stress, lipid peroxidation, iron overload, and ferroptosis of human Clear cell renal cell carcinoma (ccRCC) cell lines. Mechanistic studies identified SLC40A1 as a direct target of miR-4735-3p. | |||